Evidence that smoking cessation at first diagnosis of nonmuscle-invasive bladder cancer (NMIBC) reduces the risk of recurrence is lacking. The aim of our prospective study was to analyze the association between patients' changes in smoking habits after diagnosis and recurrence-free survival (RFS).
Serretta, V., Di Maida, F., Baiamonte, D., Vella, M., Pavone, C., Cacciatore, L., et al. (2020). Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study. UROLOGIA INTERNATIONALIS, 104((5-6)), 396-401 [10.1159/000507122].
Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study
Serretta, Vincenzo
;Baiamonte, Davide;Vella, Marco;Pavone, Carlo;Cacciatore, Loris;Valerio, Maria Rosaria;Scalici Gesolfo, Cristina;Sanfilippo, Chiara
2020-05-05
Abstract
Evidence that smoking cessation at first diagnosis of nonmuscle-invasive bladder cancer (NMIBC) reduces the risk of recurrence is lacking. The aim of our prospective study was to analyze the association between patients' changes in smoking habits after diagnosis and recurrence-free survival (RFS).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
lavoro.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
149.88 kB
Formato
Adobe PDF
|
149.88 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
